The presence of the DUX4 protein in situ has been implicated indirectly by transcriptional profiling studies finding DUX4 target genes to be statistically elevated as a group in sets of FSHD patients compared to controls [21,22]. The gene discussed is DUX4; the disease is facioscapulohumeral muscular dystrophy.